These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18474576)

  • 1. Nonclinical safety profile of telbivudine, a novel potent antiviral agent for treatment of hepatitis B.
    Bridges EG; Selden JR; Luo S
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2521-8. PubMed ID: 18474576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of telbivudine following oral administration of escalating single and multiple doses in patients with chronic hepatitis B virus infection: pharmacodynamic implications.
    Zhou XJ; Lim SG; Lloyd DM; Chao GC; Brown NA; Lai CL
    Antimicrob Agents Chemother; 2006 Mar; 50(3):874-9. PubMed ID: 16495245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telbivudine: a new nucleoside analogue for the treatment of chronic hepatitis B.
    Han SH
    Expert Opin Investig Drugs; 2005 Apr; 14(4):511-9. PubMed ID: 15882124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telbivudine: a novel nucleoside analog for chronic hepatitis B.
    Kim JW; Park SH; Louie SG
    Ann Pharmacother; 2006 Mar; 40(3):472-8. PubMed ID: 16507625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telbivudine exhibits no inhibitory activity against HIV-1 clinical isolates in vitro.
    Lin K; Karwowska S; Lam E; Limoli K; Evans TG; Avila C
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2670-3. PubMed ID: 20308377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dose-finding study of once-daily oral telbivudine in HBeAg-positive patients with chronic hepatitis B virus infection.
    Lai CL; Lim SG; Brown NA; Zhou XJ; Lloyd DM; Lee YM; Yuen MF; Chao GC; Myers MW
    Hepatology; 2004 Sep; 40(3):719-26. PubMed ID: 15349912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telbivudine in the treatment of chronic hepatitis B.
    Nash K
    Adv Ther; 2009 Feb; 26(2):155-69. PubMed ID: 19225726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic hepatitis B: focus on telbivudine.
    Lui YY; Chan HL
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):259-68. PubMed ID: 19344240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B.
    Gane EJ; Wang Y; Liaw YF; Hou J; Thongsawat S; Wan M; Moon YM; Jia J; Chao YC; Niu J; Leung N; Samuel D; Hsu CW; Bao W; Lopez P; Avila C
    Liver Int; 2011 May; 31(5):676-84. PubMed ID: 21457439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine.
    Safadi R; Xie Q; Chen Y; Yin YK; Wei L; Hwang SG; Zuckerman E; Jia JD; Lopez P
    Liver Int; 2011 May; 31(5):667-75. PubMed ID: 21040410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy and safety of telbivudine in korean patients with chronic hepatitis B].
    Moon YM; Hwang SG; Kim BS; Rim KS; Cho M; Kim DJ; Han JY; Kim YS; Choi HS; Ahn SH
    Korean J Hepatol; 2007 Dec; 13(4):503-12. PubMed ID: 18159148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of telbivudine for the management of chronic hepatitis B virus infection.
    Lui YY; Chan HL
    Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1351-61. PubMed ID: 18798704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blocking intrauterine infection by telbivudine in pregnant chronic hepatitis B patients].
    Zhang LJ; Wang L
    Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):561-3. PubMed ID: 19719910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telbivudine.
    Keam SJ
    Drugs; 2007; 67(13):1917-29. PubMed ID: 17722961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety evaluation of telbivudine.
    But DY; Yuen MF; Fung J; Lai CL
    Expert Opin Drug Saf; 2010 Sep; 9(5):821-9. PubMed ID: 20662545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment.
    Fung J; Seto WK; Lai CL; Yuen MF
    J Gastroenterol Hepatol; 2014 Mar; 29(3):428-34. PubMed ID: 24372662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B.
    Lai CL; Leung N; Teo EK; Tong M; Wong F; Hann HW; Han S; Poynard T; Myers M; Chao G; Lloyd D; Brown NA;
    Gastroenterology; 2005 Aug; 129(2):528-36. PubMed ID: 16083710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Telbivudine treatment on cirrhosis resulting from chronic hepatitis B].
    Liang J; Han T; Xiao SX
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):24-7. PubMed ID: 19203447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telbivudine: a new option for the treatment of chronic hepatitis B.
    Ruiz-Sancho A; Sheldon J; Soriano V
    Expert Opin Biol Ther; 2007 May; 7(5):751-61. PubMed ID: 17477811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telbivudine for the management of chronic hepatitis B virus infection.
    Matthews SJ
    Clin Ther; 2007 Dec; 29(12):2635-53. PubMed ID: 18201580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.